AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Eisai Co., Ltd.
$30.61
+$0.88 (+2.96%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$31
Day Range
$30.61$31.25
Year Range
$23.88$35.83
Market Cap
8.64B
AVG Volume
136
Trailing/Forward PE
31.6/0.15
PEG ratio
1.92
Dividend Yield
3.37%
Next Earnings Date
2026-11-10
Primary Exchange
Other OTC
Video analysis: ESALF
All videosNo video analysis for this stock yet. Request one from our team.
News: ESALF
Eisai Co., Ltd. (ESAIY) Q1 2027 Earnings Call Transcript
Eisai Co., Ltd. (ESAIY) Q1 2027 Earnings Call Transcript
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug
The U.S. FDA on Monday approved an at-home starting dose of Eisai's and Biogen's Alzheimer's drug, allowing some patients to begin therapy with injections administered by themselves or a caregiver.
Similar companies
-
North Bud Farms Inc.
NOBDF
·
Other OTC
Compare
-
Sysmex Corporation
SSMXF
·
Other OTC
Compare
-
Grifols, S.A.
GIFLF
·
Other OTC
Compare
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF
·
Other OTC
Compare
-
Kyowa Kirin Co., Ltd.
KYKOF
·
Other OTC
Compare
-
Shanghai Pharmaceuticals Holding Co., Ltd
SHPMF
·
Other OTC
Compare